Comparative Genomics of SARS-CoV and SARS-CoV-2 Using Fuzzy Sets: Insights into Viral Therapeutic Implications

Severe acute respiratory syndrome coronavirus (SARS-CoV) and the 2019 novel coronavirus (SARS-CoV-2) are highly infectious pathogens that primarily affect the human respiratory system, causing a range of respiratory illnesses from mild to severe. The SARS-CoV outbreak in 2003 resulted in significant global fatalities, while the ongoing COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths worldwide and has had profound impacts on healthcare systems and the global economy. Genomic analysis plays a crucial role in understanding these viruses and developing effective therapies. In this commentary, we discuss the use of genomic data, including high-throughput sequencing and gene expression analysis, in drug development for COVID-19. We highlight the similarities between the genomes of SARS-CoV and SARS-CoV-2, using fuzzy logic to estimate their distance. Our analysis indicates considerable similarity between the two genomes, suggesting potential commonalities in drug targets. The comparison of these genomes demonstrates the importance of genomics in understanding viral pathogenicity and developing targeted therapies. The use of fuzzy logic in genomic analysis provides a valuable tool for comparing genetic sequences and identifying potential drug targets. Continued research in genomics and bioinformatics is essential for combating current and future viral outbreaks